How are biological sequences defined in patent applications?
The definition of biological sequences in patent applications depends on the filing date of the application:
- For applications filed before July 1, 2022: Biological sequences are defined in 37 CFR 1.821(a).
- For applications filed on or after July 1, 2022: Biological sequences are defined in 37 CFR 1.831(b).
MPEP 608.05(c) states: “Applications disclosing nucleotide and/or amino acid sequences, as defined in 37 CFR 1.821(a) for applications filed before July 1, 2022 or as defined in 37 CFR 1.831(b) for applications filed on or after July 1, 2022, are required to provide the biological sequence information in a sequence listing.”
These definitions typically include specific criteria for nucleotide and amino acid sequences that must be disclosed in the sequence listing.
To learn more:
Topics:
Patent Law,
Patent Procedure